Nimodipine is a Ca2 channel blocker that inhibits smooth muscle contraction and relieves vascular spasm by preventing Ca2 from entering cells. It has a strong effect on cerebral arteries, can pass through the blood-brain barrier, increase cerebral blood flow, reduce ischemic brain damage, and has the effects of protecting and promoting memory and promoting intellectual recovery.

Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert its antibacterial activity. It is active against aerobic Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus).

Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci (such as Staphylococcus aureus and Staphylococcus epidermidis, Streptococcus, and Pneumococcus) and a variety of anaerobic bacteria (such as Bacteroides, Fusobacterium, Propionibacterium, Eubacterium, Actinomyces, Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus).

Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci, anaerobic Gram-negative rods, anaerobic Gram-positive non-spore-forming Bacillus, and anaerobic and microaerophilic Gram-positive rods.

Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert its antibacterial activity. It is active against aerobic Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus).